ISELA HURTIG: Open Payments
NPI 1477678308 · FALFURRIAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$635 in 36 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $635
Food & beverage: $635
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $256 |
| Lilly USA, LLC | 7 | $123 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| ABBVIE INC. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Corcept Therapeutics | 1 | $17 |
Products named: Ozempic, Rybelsus, JARDIANCE, MOUNJARO, Kerendia, FARXIGA, Wegovy, TRINTELLIX.
Industry payments across TX — which companies pay providers there.
